ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B

GlaxoSmithKline PLC Director/PDMR Shareholding (1864N)

15/01/2019 5:15pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 1864N

GlaxoSmithKline PLC

15 January 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms E N Walmsley 
===  ========================  =========================================== 
 b)   Position/status          Chief Executive Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    1535.597 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  =========================================== 
 b)   Position/status          President, Global Vaccines 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    42.320 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr S P Dingemans 
===  =========================  =========================================== 
 b)   Position/status           Chief Financial Officer 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 January 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)      Volume(s) 
                                                ---------- 
                                   GBP15.2875    1050.550 
                                                ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the               2019-01-11 
       transaction 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  =========================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    0.012 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                     Mr J Ford 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 10 
                                January 2019. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $39.4400   75.536 
                                            ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  =========================================== 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    309.578 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                   Mr N Hirons 
===  ======================  =============================================== 
 b)   Position/status        SVP, Global Ethics & Compliance 
===  ======================  =============================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  =============================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description             American Depositary Shares ('ADSs') 
       of the financial        ISIN: US37733W1053 
       instrument 
===  ======================  =============================================== 
 b)   Nature of the          Acquisition of ADSs following the re-investment 
       transaction            of dividends paid to shareholders on 10 
                              January 2019 
===  ======================  =============================================== 
 c)   Price(s) and             Price(s)   Volume(s) 
       volume(s)                          ---------- 
                                $39.4400   18.799 
                                          ---------- 
===  ======================  =============================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  =============================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  =============================================== 
 f)   Place of the           New York Stock Exchange (XNYS) 
       transaction 
===  ======================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                    Mr B McNamara 
===  =======================  =============================================== 
 b)   Position/status         CEO, GSK Consumer Healthcare 
===  =======================  =============================================== 
 c)   Initial notification/   Initial notification 
       amendment 
===  =======================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  =============================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description              American Depositary Shares ('ADSs') 
       of the financial         ISIN: US37733W1053 
       instrument 
===  =======================  =============================================== 
 b)   Nature of the           Acquisition of ADSs following the re-investment 
       transaction             of dividends paid to shareholders on 10 
                               January 2019 
===  =======================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                           ---------- 
                                 $39.4400   424.074 
                                           ---------- 
===  =======================  =============================================== 
 d)   Aggregated information  n/a (single transaction) 
       Aggregated volume 
       Price 
===  =======================  =============================================== 
 e)   Date of the             2019-01-11 
       transaction 
===  =======================  =============================================== 
 f)   Place of the            New York Stock Exchange (XNYS) 
       transaction 
===  =======================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr D Redfern 
===  ========================  =========================================== 
 b)   Position/status          Chief Strategy Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.2875   1945.478 
                                              ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  =========================================== 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    363.181 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms C Thomas 
===  ========================  =========================================== 
 b)   Position/status          SVP, Human Resources 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    357.061 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ============================================================================ 
 a)   Name                   Mr P C Thomson 
===  ======================  ==================================================== 
 b)   Position/status        President, Global Affairs 
===  ======================  ==================================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ==================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ============================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ==================================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ==================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================================ 
 a)   Description            Ordinary shares of 25 pence each ('Ordinary 
       of the financial       Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ==================================================== 
 b)   Nature of the          Acquisition of Ordinary Shares following 
       transaction            the re-investment of dividends paid to shareholders 
                              on 10 January 2019. 
===  ======================  ==================================================== 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)                             ---------- 
                                GBP15.2875    210.297 
                                             ---------- 
===  ======================  ==================================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ==================================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  ==================================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ==================================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ============================================================================ 
 a)   Name                   Mrs K Thomson 
===  ======================  ==================================================== 
 b)   Position/status        PCA of Mr P C Thomson (President, Global 
                              Affairs) 
===  ======================  ==================================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ==================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ============================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ==================================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ==================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================================ 
 a)   Description            Ordinary shares of 25 pence each ('Ordinary 
       of the financial       Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ==================================================== 
 b)   Nature of the          Acquisition of Ordinary Shares following 
       transaction            the re-investment of dividends paid to shareholders 
                              on 10 January 2019. 
===  ======================  ==================================================== 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)                             ---------- 
                                GBP15.2875    127.445 
                                             ---------- 
===  ======================  ==================================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ==================================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  ==================================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ==================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDELFFKFFFBBX

(END) Dow Jones Newswires

January 15, 2019 12:15 ET (17:15 GMT)

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock